Data gathered: December 9
Data Bits
Data Bits | Value / Change | Benchmark | |
---|---|---|---|
Job Posts | N/A | N/A | |
Sentiment | N/A | N/A | |
Webpage traffic | N/A | N/A | |
Employee Rating | N/A | N/A | |
Linkedin Employees | N/A | N/A | |
Patents | N/A | N/A | |
4chan Mentions | N/A | N/A | |
Stocktwits Mentions | N/A | N/A | |
Stocktwits Subscribers | N/A | N/A | |
Twitter Followers | N/A | N/A | |
News Mentions | N/A | N/A | |
Reddit Mentions | N/A | N/A | |
Business outlook | N/A | N/A |
In the news
12 Best Healthcare Stocks For the Long-TermDecember 7 - Yahoo |
|
BioNTech : and Australia’s State of Victoria Sign Agreement on Strategic Partnership to Strengthen mRNA Ecosystem - Form 6-KDecember 7 - Finnhub |
|
BioNTech : and Australia’s State of Victoria Sign Agreement on Strategic Partnership to Strengthen mRNA EcosystemDecember 7 - Finnhub |
|
![]() |
FactChecking the Fourth GOP Primary DebateDecember 6 - FactCheck.org |
![]() |
Research: Certain COVID-19 Vaccines May Lead to Neuromyelitis OpticaDecember 6 - Theepochtimes.com |
BioNTech SE ADR rises Thursday, still underperforms marketDecember 6 - MarketWatch |
About BioNTech
BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases.

Price | $103.3 |
Target Price | Sign up |
Market Cap | $24.4B |
Dividend Yield | 0.0132 |
Industry | Biotechnology |
Similar companies
Company | Price | AI Score |
---|
Financial performance View All
Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
---|---|---|---|---|---|
Q3 '23 | 895M | 660M | 236M | 161M | 216M |
Q2 '23 | 168M | 536M | -369M | -190M | -379M |
Q1 '23 | 1.28B | 430M | 847M | 502M | 841M |
Q4 '22 | 4.28B | 693M | 3.59B | 2.28B | 3.36B |
Q3 '22 | 3.46B | 1.09B | 2.37B | 1.78B | 2.26B |